117 related articles for article (PubMed ID: 24330516)
1. The long term effectiveness and cost-effectiveness of initiating treatment for ocular hypertension.
van Gestel A; Schouten JS; Beckers HJ; Severens JL; Hendrikse F; Webers CA
Acta Ophthalmol; 2014 Sep; 92(6):513-23. PubMed ID: 24330516
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of treating ocular hypertension.
Stewart WC; Stewart JA; Nasser QJ; Mychaskiw MA
Ophthalmology; 2008 Jan; 115(1):94-8. PubMed ID: 18166406
[TBL] [Abstract][Full Text] [Related]
3. Latanoprost versus timolol as first choice therapy in patients with ocular hypertension. A cost-effectiveness analysis.
Peeters A; Schouten JS; Severens JL; Hendrikse F; Prins MH; Webers CA
Acta Ophthalmol; 2012 Mar; 90(2):146-54. PubMed ID: 20731623
[TBL] [Abstract][Full Text] [Related]
4. The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma.
van Gestel A; Webers CA; Severens JL; Beckers HJ; Jansonius NM; Hendrikse F; Schouten JS
Acta Ophthalmol; 2012 Feb; 90(1):20-31. PubMed ID: 22289192
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist.
Peeters A; Schouten JS; Webers CA; Prins MH; Hendrikse F; Severens JL
Eye (Lond); 2008 Mar; 22(3):354-62. PubMed ID: 17128205
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness.
Tuulonen A; Azuara-Blanco A
Ophthalmology; 2009 Jan; 116(1):166-7; author reply 167. PubMed ID: 19118707
[No Abstract] [Full Text] [Related]
8. Cost-effectiveness.
Brown GC; Brown MM
Ophthalmology; 2008 Aug; 115(8):1433; author reply 1433-4. PubMed ID: 18675701
[No Abstract] [Full Text] [Related]
9. Cost-effectiveness.
Lichter PR
Ophthalmology; 2008 Oct; 115(10):1852-3; author reply 1853. PubMed ID: 18929170
[No Abstract] [Full Text] [Related]
10. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection.
Gazelle GS; McMahon PM; Beinfeld MT; Halpern EF; Weinstein MC
Radiology; 2004 Dec; 233(3):729-39. PubMed ID: 15564408
[TBL] [Abstract][Full Text] [Related]
11. Surveillance for ocular hypertension: an evidence synthesis and economic evaluation.
Burr JM; Botello-Pinzon P; Takwoingi Y; Hernández R; Vazquez-Montes M; Elders A; Asaoka R; Banister K; van der Schoot J; Fraser C; King A; Lemij H; Sanders R; Vernon S; Tuulonen A; Kotecha A; Glasziou P; Garway-Heath D; Crabb D; Vale L; Azuara-Blanco A; Perera R; Ryan M; Deeks J; Cook J
Health Technol Assess; 2012 Jun; 16(29):1-271, iii-iv. PubMed ID: 22687263
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of prostacyclins in pulmonary arterial hypertension.
Roman A; Barberà JA; Escribano P; Sala ML; Febrer L; Oyagüez I; Sabater E; Casado MA
Appl Health Econ Health Policy; 2012 May; 10(3):175-88. PubMed ID: 22452448
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
Noecker RJ; Walt JG
Am J Ophthalmol; 2006 Jan; 141(1 Suppl):S15-21. PubMed ID: 16389056
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.
Brown GC; Brown MM; Lieske HB; Lieske PA; Brown KS; Lane SS
Ophthalmology; 2011 Sep; 118(9):1834-43. PubMed ID: 21723614
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of treating normal tension glaucoma.
Li EY; Tham CC; Chi SC; Lam DS
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3394-9. PubMed ID: 23599342
[TBL] [Abstract][Full Text] [Related]
16. A comparison of open and endovascular revascularization for chronic mesenteric ischemia in a clinical decision model.
Hogendoorn W; Hunink MG; Schlösser FJ; Moll FL; Muhs BE; Sumpio BE
J Vasc Surg; 2014 Sep; 60(3):715-25.e2. PubMed ID: 24721175
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.
Geisler BP; Egan BM; Cohen JT; Garner AM; Akehurst RL; Esler MD; Pietzsch JB
J Am Coll Cardiol; 2012 Oct; 60(14):1271-7. PubMed ID: 22981547
[TBL] [Abstract][Full Text] [Related]
18. Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension.
Dorenkamp M; Bonaventura K; Leber AW; Boldt J; Sohns C; Boldt LH; Haverkamp W; Frei U; Roser M
Eur Heart J; 2013 Feb; 34(6):451-61. PubMed ID: 23091202
[TBL] [Abstract][Full Text] [Related]
19. [An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients].
Rouland JF; Peigne G; Sellem E; Renard JP; Williamson W; Filippi JM; Cohn H; Hamard P; Abellan P; Chagnon A; Malet F; Haye I
J Fr Ophtalmol; 2001 Mar; 24(3):233-43. PubMed ID: 11285438
[TBL] [Abstract][Full Text] [Related]
20. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]